Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Heliyon ; 9(11): e21713, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38027612

RESUMO

The concept of sepsis has recently evolved from one of a 'systemic inflammatory response syndrome caused by infection' to a 'severe, potentially fatal organic dysfunction caused by an inadequate or imbalanced host response to infection'. Organ dysfunction is closely related to sepsis. Multiple organ dysfunction syndrome (MODS) is the most serious outcome of sepsis, often leading to a poor prognosis. However, specific drugs for sepsis and MODS caused by sepsis remain undetermined, and the fatality rate is relatively high. Under the guidance of modern medicine, traditional Chinese medicine (TCM) has gained a wealth of experience in the prevention and treatment of sepsis and plays a key role via the effects of its numerous components, pathways and targets. This study used 'Sepsis', 'Organ dysfunction' and 'Traditional Chinese medicine' as strategies for searching the databases of Chinese National Knowledge Infrastructure, Wanfang, PubMed and The Web of Science. This paper presents an overview of the current status of TCM component formulations for preventing and treating sepsis with MODS to provide a theoretical basis for clinical treatment and drug development.

2.
Artigo em Inglês | MEDLINE | ID: mdl-35656456

RESUMO

Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635).

3.
Zhongguo Zhong Yao Za Zhi ; 47(10): 2634-2642, 2022 May.
Artigo em Chinês | MEDLINE | ID: mdl-35718481

RESUMO

On the basis of previous studies, this study prepared and evaluated microemulsion gel loading enriched ingredients of Epimedii Folium and investigated its protective effect against peripheral nervous system damage caused by chemotherapeutics. The preparation method and the type and dosage of the matrix were investigated from rheology, preparation difficulty, and drug loading. Then the optimal prescription was determined and the microemulsion gel loading enriched ingredients of Epimedii Folium was prepared. The in vitro release and transdermal behaviors of the gel were investigated in the Franz diffusion cell with epimedin A1,A,B,C, and icariin as evaluation indicators. The oxaliplatin-induced peripheral neuropathy(OIPN) model was established in Wistar rats. The protective effect of the microemulsion gel loading enriched ingredients of Epimedii Folium against peripheral nervous system damage caused by chemotherapeutics was evaluated by behavioral measurement after drug administration and histopathological examination of dorsal root ganglia and sciatic nerve. The preparation process of the microemulsion gel loading enriched ingredients of Epimedii Folium was stable, and the release of the five components was consistent with the Hixson-Crowell cube root law. Behavioral indicators intuitively showed that the drug could effectively relieve mechanical allodynia caused by oxaliplatin. The histopathological examination showed that the drug can improve neuron damage in the dorsal root ganglia, axon degeneration, and demyelination caused by oxaliplatin. Therefore, the preparation process of the microemulsion gel loading enriched ingredients of Epimedii Folium is feasible, which can achieve stable drug release. It has a certain therapeutic effect on chemotherapy-induced peripheral neuropathy(CIPN).


Assuntos
Medicamentos de Ervas Chinesas , Doenças do Sistema Nervoso Periférico , Animais , Medicamentos de Ervas Chinesas/uso terapêutico , Oxaliplatina/efeitos adversos , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Ratos , Ratos Wistar
4.
Radiat Prot Dosimetry ; 198(1-2): 109-118, 2022 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-35106600

RESUMO

An environmental radioactivity survey was performed on a uranium mine that has been decommissioned for >10 y. According to the characteristics of this uranium mine, the relevant parameters, such as the surface-absorbed dose rate in air, the radon and radon progeny concentrations in the air, the radon exhalation rate from the soil surface and the concentrations of natural radionuclides in soil and surface water, were measured. The results show that the maximum annual effective doses of residents and employees in the uranium mine caused by radon and radon progenies inhalation were 1.48 and 1.74 mSv, respectively, and the maximum annual effective doses of residents and employees caused by gamma-ray external radiation were 1.16 and 1.32 mSv, respectively.


Assuntos
Poluentes Radioativos do Ar , Monitoramento de Radiação , Radioatividade , Radônio , Urânio , Poluentes Radioativos do Ar/análise , Monitoramento de Radiação/métodos , Radônio/análise , Produtos de Decaimento de Radônio , Urânio/análise
5.
Zhongguo Zhong Yao Za Zhi ; 46(20): 5284-5290, 2021 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-34738431

RESUMO

This study aimed to investigate the enhancing effect of muscone on the transdermal penetration of traditional Chinese medicine ingredients and explore its possible mechanism of action. The Franz diffusion cells were employed to investigate the effect of muscone on the transdermal permeation of a series of model drugs with a wide range of log P values. The solubilities at saturation and the stratum corneum(SC)/vehicle partition coefficients of model drugs were measured to evaluate the effect of muscone on drug thermodynamic activities and partition of drugs into SC. Attenuated total reflectance-Fourier transform infrared spectroscopy(ATR-FTIR) was employed to explore the effect of muscone on the molecular structure of SC. The results showed that muscone significantly promoted the transdermal penetration of hydrophilic and lipophilic drugs, and the enhancement ratio(ER) increased with the decrease in the log P. Muscone could interact with the SC lipids to increase the disorder and fluidity of lipid bilayer packing, which improved skin permeability and promoted transdermal absorption of drugs. This study provides a scientific basis for the application of muscone in traditional Chinese medicine topical preparations.


Assuntos
Medicina Tradicional Chinesa , Absorção Cutânea , Administração Cutânea , Animais , Cicloparafinas , Permeabilidade , Ratos , Ratos Sprague-Dawley , Pele/metabolismo
6.
BMJ Open ; 10(11): e040473, 2020 11 26.
Artigo em Inglês | MEDLINE | ID: mdl-33243802

RESUMO

OBJECTIVES: This study aimed to characterise the prescribing patterns and evaluate the appropriateness of the prescribed proton pump inhibitors (PPIs) in adult patients via a review of electronic medical records in a single-centred hospital. DESIGN: All patients admitted to the outpatient department of Jinshan Hospital, Fudan University, Shanghai, between 1 January 2018 and 31 December 2018 were evaluated. Individuals aged 18 years or above and with at least one dispensing for PPIs were identified as PPI users. New PPI users were defined as a subject who did not receive any dispensing for PPIs in the year prior to the index date. Baseline characteristics of PPI users and their therapies were described by treatment indication, economic indicators and co-prescription, overall and separately. SETTING: The prescription database was retrieved from the hospital information system of Jinshan Hospital, Fudan University. RESULTS: Among 18 435 identified PPI users in 2018, 14 219 patients (aged 18 years or above) who had at least one dispensing PPIs were new users (77%), and among them, men accounted for 47%. The mean treatment duration was 23 days. Omeprazole was the most commonly prescribed drug. PPIs are inappropriately prescribed in 50% (13 589/25 850) of prescriptions. Prescription appropriateness analysis indicated that the unapproved indications for PPI new users accounted for 47%; among them, the proportion of gastritis diagnosis was 34%. The proportion of PPI new users with co-prescription of glucocorticosteroids (GCs) who have risk factors accounted for 24% and lower than other co-prescription. A majority of PPI users (73%) reported high-dose PPI prescription. The defined daily dose of oral pantoprazole was the highest, and injectable omeprazole had the highest defined daily cost. In contrast, only the drug utilisation index value of oral esomeprazole was less than 1.0. CONCLUSION: The results indicate the challenge of PPI use was accompanied by unapproved indications, frequent inappropriate co-prescription with GCs and excessive dosages. Efforts should be paid to promote rational use and ensure the choice of suitable PPI therapy in the future.


Assuntos
Prescrição Inadequada , Inibidores da Bomba de Prótons/uso terapêutico , Adolescente , Adulto , Idoso , China , Esomeprazol , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Padrões de Prática Médica , Estudos Retrospectivos , Adulto Jovem
7.
Radiat Prot Dosimetry ; 189(3): 337-346, 2020 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-32328649

RESUMO

The environmental radioactivity levels of two typical uranium mines in the south of China were investigated and analysed. According to the characteristics of uranium mines, the relevant parameters, including the surface gamma ray dose rate, concentration of radon in the air and concentration of radionuclides in the soil and surface water, of two uranium mines were evaluated and analysed. The results show that residents in the mining area were exposed to average maximum annual effective doses of 1.69 and 1.58 mSv due to the inhalation of radon and its daughters, while the employees received 2.59 and 1.87 mSv, respectively. Residents in the mining area were exposed to average maximum annual effective doses of 0.77 and 0.69 mSv due to gamma ray, while the employees received 1.64 and 1.33 mSv, respectively.


Assuntos
Monitoramento de Radiação , Radioatividade , Radônio , Urânio , China , Radônio/análise
8.
Acta Pharmacol Sin ; 36(9): 1065-73, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26279157

RESUMO

AIM: To investigate the effects of calcium and vitamin D supplementation on bone turnover marker levels, muscle strength and quality of life in postmenopausal Chinese women. METHODS: A total of 485 healthy postmenopausal Chinese women (63.44±5.04 years) were enrolled in this open-label, 2-year, prospective, community-based trial. The participants were divided into group A, B, C, which were treated with calcium (600 mg/d) alone, calcium (600 mg/d) and cholecalciferol (800 IU/d) or calcium (600 mg/d) and calcitriol (0.25 µg/d), respectively, for 2 years. Serum levels of 25-hydroxyvitamin D, parathyroid hormone, ß-CTX and P1NP were measured, and the muscle strength and quality of life were assessed at baseline and at 12- and 24-month follow-ups. RESULTS: Four hundred and sixty one participants completed this study. Serum levels of 25-hydroxyvitamin D were significantly increased in group C, but not changed in groups A and B at 24-month follow-up. Serum levels of parathyroid hormone, bone turnover marker ß-CTX and bone formation marker P1NP were significantly decreased in group C, while serum levels of ß-CTX were increased in group A at 24-month follow-up. The participants in group C maintained the grip strength, while those in groups A and B exhibited decreased grip strength at 24-month follow-up. The quality of life for the participants in groups B and C remained consistent, but that in group A was deteriorated at 24-month follow-up. CONCLUSION: Supplementation with calcitriol and calcium modifies the bone turnover marker levels, and maintains muscle strength and quality of life in postmenopausal Chinese women, whereas supplementation with cholecalciferol and calcium prevents aging-mediated deterioration in quality of life.


Assuntos
Calcitriol/farmacologia , Cálcio/farmacologia , Colecalciferol/farmacologia , Pós-Menopausa , Qualidade de Vida , Vitaminas/farmacologia , Idoso , Conservadores da Densidade Óssea/administração & dosagem , Conservadores da Densidade Óssea/farmacologia , Remodelação Óssea/efeitos dos fármacos , Calcitriol/administração & dosagem , Cálcio/administração & dosagem , China , Colecalciferol/administração & dosagem , Suplementos Nutricionais/análise , Feminino , Força da Mão , Humanos , Pessoa de Meia-Idade , Força Muscular/efeitos dos fármacos , Estudos Prospectivos , Vitamina D/análogos & derivados , Vitamina D/sangue , Vitaminas/administração & dosagem
9.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi ; 23(4): 397-401, 2006 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-16883525

RESUMO

OBJECTIVE: To investigate the association of polymorphisms of start codon (Fok I site) and CDX2 binding site in vitamin D receptor gene (VDR) concerned with the effect of calcium supplementation on bone mineral density (BMD) and bone turnover markers of postmenopausal women. METHODS: Two hundreds unrelated postmenopausal women of Han ethnicity in Shanghai were randomly divided into 2 groups of 100 women: high calcium group (1000 mg element calcium and 400 units of vitamin D were given daily for 12 months) and low calcium group (300 mg element calcium and 300 units of vitamin D were given daily for 12 months). BMD and bone turnover markers were measured at baseline and 12 months after calcium supplementation. VDR gene Fok I and CDX2 polymorphisms were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and allele-specific multiplex PCR, respectively. RESULTS: One hundred and seventy-one women completed 12-month study period. The frequency of VDR Fok I genotypes was 48.0 % for Ff, 31.0 % for FF, and 21.0 % for ff, and the frequency of CDX2 genotypes was 56.7 % for AG, 25.7% for GG, and 17.6% for AA. The frequencies distribution of Fok I and CDX2 alleles in the entire population or in two subgroups all followed the Hardy-Weinberg equilibrium. No significant difference of baseline BMD and bone turnover markers in Fok I genotypes or CDX2 genotypes was observed in the entire population or in two subgroups. Moreover, regardless of calcium supplementation given for 12 months, no significant association was found between Fok I or CDX2 polymorphisms and the endpoint values or percentage changes of any BMD and bone turnover markers in either high calcium group or low calcium group. CONCLUSION: There is no significant relationship between VDR gene Fok I or CDX2 polymorphisms and the effect of high or low doses calcium supplementation on BMD and bone turnover markers in Shanghai postmenopausal women of Han ethnicity.


Assuntos
Densidade Óssea/efeitos dos fármacos , Cálcio da Dieta/uso terapêutico , Códon de Iniciação/genética , Polimorfismo Genético/genética , Receptores de Calcitriol/genética , Idoso , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Cálcio da Dieta/administração & dosagem , Suplementos Nutricionais , Quimioterapia Combinada , Feminino , Frequência do Gene , Genótipo , Humanos , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/prevenção & controle , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Pós-Menopausa/efeitos dos fármacos , Vitamina D/administração & dosagem , Vitamina D/uso terapêutico , Vitaminas/administração & dosagem , Vitaminas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA